The COVID-19 pandemic continues to cast a long shadow over public trust, scientific institutions, and political leadership. On Thursday, Health and Human Services Secretary Robert F. Kennedy Jr. reignited controversy during a Senate Finance Committee hearing, claiming that the federal government had misled Americans about nearly every aspect of the pandemic response. His comments touched off a heated debate that underscored just how polarizing the conversation around vaccines, masks, and public health remains—even five years after the virus first spread across the globe.

When asked by Senator John Cornyn (R-Texas) whether he believed COVID-19 had been politicized, Kennedy’s response was blunt: “The whole process was politicized. We were lied to about everything.” He accused the Centers for Disease Control and Prevention (CDC) and other federal agencies of concealing the truth about natural immunity, overstating the power of vaccines to block transmission, and misleading the public on the effectiveness of cloth masks.

Also Read: Joe Biden Undergoes Surgery To Remove Skin Cancer Months After Prostate Cancer Diagnosis

Kennedy framed his stance as an effort to “eliminate politics from science,” but his words also echoed his long history of skepticism toward vaccines, a position that has drawn sharp criticism from leading medical organizations.

Vaccines and the Debate Over Transmission

One of Kennedy’s more pointed critiques involved the early messaging on COVID-19 vaccines. In 2021, then-CDC Director Rochelle Walensky said data suggested vaccinated individuals “do not carry the virus, don’t get sick.” That statement, later walked back, has since been cited by skeptics as evidence of misleading communication.

The official guidance at the time, however, noted that vaccines primarily reduced the risk of severe illness and transmission—they did not guarantee complete immunity. Subsequent data confirmed that while breakthrough infections occurred, vaccination significantly lowered the risk of hospitalization and death. Critics argue that Kennedy’s selective framing ignores this broader reality.

Mask Guidance: Shifting Science or Mixed Messaging?

Kennedy also attacked the government’s changing stance on masks. Early in the pandemic, cloth masks were encouraged when medical-grade masks were in short supply. Over time, the CDC emphasized higher filtration masks like N95s and KN95s as the standard for protection.

Public health experts acknowledge that these shifts were confusing but stress they reflected evolving evidence and supply-chain realities, not intentional deception. Kennedy, however, portrayed them as emblematic of a government that “failed miserably during COVID.”

COVID-19 In US: How Many Died?

The most tense exchange of the hearing came when Senator Mark Warner (D-Va.) pressed Kennedy on the U.S. death toll. “How many Americans died from COVID-19?” Warner asked. Kennedy responded: “I don’t think anybody knows.”

According to CDC data—an agency Kennedy oversees—over 1.23 million Americans have died from COVID-19 as of August 2025. Warner, visibly frustrated, accused the health secretary of ignorance and undermining public confidence. “You are sitting as Secretary of Health and Human Services—how can you be that ignorant?” Warner demanded.

Kennedy countered by accusing the Biden administration of creating “data chaos,” suggesting inconsistencies in mortality reporting eroded public trust.

Tensions Over Vaccine Access

The hearing also spotlighted vaccine access. Senator Bill Cassidy (R-La.), a physician, challenged Kennedy over his role in narrowing vaccine recommendations and replacing expert panels with his own appointees. Cassidy warned that conflicting guidance was making it harder for Americans to access booster shots.

“Effectively, we are denying people vaccines,” Cassidy said. Kennedy flatly rejected the claim: “You’re wrong.” The clash highlighted an underlying paradox—while Kennedy acknowledged Trump’s Operation Warp Speed as a success deserving of a Nobel Prize, he has simultaneously pursued policies that critics say restrict vaccine uptake.

The Fallout at CDC and Leadership Shake-Ups

Kennedy defended his decision to fire CDC Director Susan Monarez after less than a month on the job, a move that triggered several high-level resignations. He called the shake-ups “absolutely necessary,” arguing that the CDC’s leadership had “failed miserably during COVID.”

His critics, including more than 20 medical societies calling for his resignation, argue the opposite—that Kennedy has destabilized one of the country’s most vital public health agencies at a critical time. For them, the firing represents not accountability, but a dismantling of scientific infrastructure.

Fractured Trust in Science and Government

Kennedy’s claim that “we were lied to about everything” taps into deep public skepticism that grew throughout the pandemic. Mixed messaging on masks, shifting vaccine recommendations, and partisan rhetoric all fueled a breakdown in trust.

But public health experts caution that framing this as deliberate deceit oversimplifies a far more complex reality. Science evolves with new data, and policies must adapt accordingly. While communication missteps occurred, the broad consensus among experts remains that vaccines saved millions of lives, masks reduced spread, and public health interventions—though imperfect—were essential.

A Political and Public Health Crossroads

What Kennedy’s testimony underscored most clearly is the enduring politicization of COVID-19. His words resonated with those already skeptical of government institutions but alarmed many physicians and scientists who see them as undermining progress in future health crises.

The tension between politics and public health is unlikely to fade. With respiratory virus season approaching, debates over vaccines, mask mandates, and data transparency remain unresolved. The hearing revealed not just disagreements over past actions, but ongoing battles over how the U.S. should prepare for future pandemics.

Robert F. Kennedy Jr.’s claim that Americans “were lied to about everything” may capture the anger of those disillusioned with government response, but it also risks entrenching misinformation. The legacy of COVID-19 is not only measured in lives lost but also in fractured trust between citizens, science, and leadership.

As policymakers and public health leaders move forward, the question remains, will lessons from the pandemic bring stronger systems and clearer communication, or will the scars of political division continue to shape health policy for years to come?

This is a developing story, we are looking into data mentioned and will bring you more detailed information soon.

All India Institute of Medical Sciences (AIIMS) and the Indian Space Research Organisation (ISRO) signed a Memorandum of Understanding (MoU) on Monday to collaborate on advancing research in space medicine.

The MoU was signed between M Srinivas, Director (AIIMS), New Delhi and Dinesh Kumar Singh, Director, Human Space Flight Centre (HSFC), ISRO. The event brought together senior leadership from AIIMS and ISRO, including ISRO Chairman V Narayanan and Secretary, Department of Space, as well as Deans, Heads of Departments, faculty members, and studies from AIIMS New Delhi.

As per the news agency Asian News International (ANI), a press release of the collaboration noted for a cooperative framework for ground-based and space-based research in Space Medicine. The press release also noted that the research will cover areas like human physiology, cardiovascular and autonomic regulation, musculoskeletal health in microgravity, microbiome and immunology, genomics and biomarkers and behavioral health.

“This MoU will give us the escape velocity to venture together into the field of space medicine. Collaborative research between AIIMS and ISRO will benefit patients, the nation, and ultimately humankind. As India moves toward Viksit Bharat by 2047, we hope to emerge as a Vishwaguru in space medicine as well,” said Prof M Srinivas, Director, AIIMS, New Delhi.

Chairman of ISRO Dr V Narayanan and Secretary, Department of Space also highlighted India’s remarkable journey in space programme. He noted how India evolved from the time when rockets and equipment were transported on bicycles and bullock carts to today, where it is going to be leading medical and research institutions like AIIMS to strengthen India’s human spaceflight capabilities.

The programme also featured a presentation on AIIMS New Delhi’s ongoing work in space medicine research, delivered by Prof. KK Deepak, former Head of the Department of Physiology. The event was attended by Heads of Departments and faculty members from across AIIMS New Delhi, along with representatives from the Resident Doctors Association (RDA), the AIIMS Student Association (ASA), and the Society of Young Scientists (SYS).

The collaboration represents an important step toward enhancing India’s capabilities in human spaceflight and biomedical research. It also aligns with the country’s broader scientific ambitions as India moves toward its centenary in 2047 and the vision of Viksit Bharat.

Read: Sunita Williams Retires After 27 Years: Health Challenges She Faced After Spending 600+ Days in Space

What Do We Already Know About Space Medicine?

As per a 2017 study in the British Journal of Anaesthesia, space medicine is fundamental to the human exploration of space. It supports survival, function and performance in this challenging as potentially lethal environment. It is international, intercultural and interdisciplinary, operating at the boundaries of exploration, science, technology and medicine.

Space medicine specialists play a crucial role in safeguarding astronauts and other spaceflight participants. Known as “flight surgeons,” they help develop strategies to protect the health, safety, and performance of space travellers in the extreme conditions of space. Their responsibilities span every stage of a mission — from selection and training to in-flight care, post-mission rehabilitation, and monitoring long-term health effects.

With inputs from ANI

Sick days are again piling up with a respiratory disease, not COVID-19 or the flu. This disease is most likely the one Americans have not heard of. This is HMPV or human metapneumovirus. Doctors have asked people to stay vigilant as seasonal flu virus could lead to pneumonia and bronchitis, and it is spreading in California wastewater and around the country. However, as per public health officials, there is nothing to get worried at this point.

Also Read: Is There A Link Between Your Kidney Health And Other Chronic Diseases? Study Says Yes

As per the public database WasterwaterScan Dashboard, high levels of HMPV were detected across Northern California cities. The highest levels were reported in Redwood City, whereas elevated levels were found in San Francisco Bay Area and Napa's Wine Country. What's more dangerous is that this virus is without a vaccine.

The good news is that in other parts of country HMPV remains lower. However, the Centers for Disease Control and Prevention (CDC) noted that data from October 2025 shows the cases are trending up, especially during winter and spring.

Dr. Matthew Binnicker, director of the Clinical Virology Laboratory at Mayo Clinic, as reported by The Independent said, "In the late winter, early spring, it can account for five percent to 10 percent of all the respiratory infections that we diagnose in the United States. So it's definitely out there." Experts explain that other viruses like HMPV or influenza get a chance when COVID is quieter.

Read: HMPV Virus Cases Surging In California, New Jersey: Is It Dangerous?

Virus Without A Vaccine: What Is HMPV?

HMPV was first discovered in 2001 and is part of the Pneumoviridae family along with the Respiratory syncytial virus (RSV).

HMPV most likely spreads from an infected person to others through:

• the air by coughing and sneezing
• close personal contact, such as touching or shaking hands
• touching objects or surfaces that have the viruses on them, then touching the mouth, nose, or eyes

In the US, HMPV circulates in predictable patterns each year, typically beginning in winter and lasting through spring.

The usually self-limiting and mild symptoms typically last 4 to 5 days. These include:

• cough
• fever
• nasal congestion
• shortness of breath

People at risk include:

• elderly people
• children
• people with comorbidities

"The HMPV is not deadly, and there is no evidence of mortality or a severe transmission rate," former Indian Council of Medical Research (ICMR) scientist, Dr. Raman Gangakhedkar, told IANS, during the virus's outbreak in India in 2025.

“The virus may cause pneumonitis-like illness, but the mortality rates are almost unknown so far. HMPV has a global prevalence of about 4 per cent,” he added.

While no vaccine or treatment can prevent HMPV infection, to avoid the infection, individuals must:

Practice good hygiene and cover your mouth and nose with a tissue when coughing or sneezing, or use your elbow, not your hands, for it. And wash your hands properly, especially in healthcare settings.

Why Are People Hearing About The Virus Without Vaccine Now?

The reason people have not heard about it before is because its symptoms are nearly indistinguishable from other respiratory infections, so often it could go undiagnosed. Furthermore, earlier the COVID cases and influenza cases sparked up, which deviated the attention from HMPV. Now, with the season gone, and increased awareness around respiratory illnesses, greater attention to viruses like HMPV is also paid.

One in seven Indians, or over 14 percent of the population, suffers from some form of mental health disorder. Amid an increasing treatment gap -- up to 90 percent -- seen in several states, especially in North India, the government today reiterated the plan of launching a second National Institute of Mental Health and Neurosciences (NIMHANS) in the northern states.

NIMHANS-2 was first announced by Finance Minister Nirmala Sitharaman during the Union Budget 2026-27, to deliver specialized care for mental health and neurological disorders in north India.

Health experts and policymakers, as part of the government-led Post-Budget Webinar series, highlighted the growing burden of mental and neurological disorders in India and also stressed the urgent need to strengthen institutional capacity to meet emerging healthcare demands.

"One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 percent," the experts said.

Noting that Non-Communicable Diseases (NCDs) account for over 60 percent of deaths in the country, they added that "neurological and mental health conditions are among the leading contributors to disability-adjusted life years (DALYs)," among the citizens.

Need For Tertiary Neuro-psychiatric Care

To address these, the experts called for ramping up tertiary mental health institutions and expanding specialized services.

The session, moderated by Vijay Nehra, Joint Secretary, Ministry of Health and Family Welfare, highlighted that North India currently lacks adequate tertiary neuro-psychiatric care facilities. These include areas such as:

• advanced neuroimaging,
• neurocritical care,
• specialized neurological services

Further, making a virtual address at the Post-Budget Webinar, Union Health Minister JP Nadda also highlighted the government’s focus on strengthening mental healthcare services in the country.

"NIMHANS-2 will be established in North India to expand advanced clinical care, training, and research," Nadda said.

"In addition, the Central Institute of Psychiatry, Ranchi, and the Lokopriya Gopinath Bordoloi Regional Institute of Mental Health, Tezpur, will be upgraded as regional apex institutions to strengthen mental healthcare services in the eastern and north-eastern regions," he added.

Meanwhile, the experts also stressed the need to improve services in underserved and geographically remote regions, including the northeastern states, through better infrastructure, capacity building, and targeted deployment of trained mental health professionals.

They also discussed strategies for expanding advanced neuro-psychiatric care and reinforcing India’s overall mental healthcare ecosystem. They proposed:

• Adopting a hub-and-spoke model supported by digital health platforms

This would allow tertiary institutions and centers of excellence to provide technical guidance, specialist consultations, and clinical support to district hospitals and community-level health facilities.

"Such a model would strengthen referral pathways and ensure that specialized mental health services are accessible to people even in remote and rural areas," the experts said.

• Integrating services under Tele-MANAS

Both existing and upcoming campuses of NIMHANS must be integrated , as this will enable a robust nationwide tele-mental health network that ensures

• timely counselling,
• psychological support,
• specialist consultations

• Digital follow-up systems

The experts called for the seamless integration of healthcare facilities, aligned with the vision of the Ayushman Bharat Digital Mission and the ABHA ID ecosystem. This, they said, will

• enable continuity of care,
• Improve monitoring of patients,
• Lead to better clinical outcomes

• A national Brain-Mind Cloud Network

The Network proposed under the National Health Mission would connect premier institutions such as All India Institute of Medical Sciences (AIIMS), state medical colleges, and primary healthcare centers through a digitally integrated platform.

It could also facilitate

• unified mental health records,
• AI-based screening tools,
• data-driven clinical decision support systems,
• tele-neuro-psychiatric hubs at regional centers.